Phase II study of cytosine arabinoside in advanced large bowel cancer.
D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000188:drug therapy*; D003561:Cytarabine / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D012004:Rectal Neoplasms / Q000188:drug therapy*
D003561:Cytarabine